Published in Hepatitis Weekly, September 11th, 2006
"In HCV-infected patients, it is generally assumed that the pattern of response to antiviral therapy remains unaltered after LT. However, changes in the circulating HCV quasispecies and in the gene expression profiles of the graft might influence response to treatment after LT," wrote A. Feliu and colleagues, Institut d'Investigacions Biomediques August Pi i Sunyer.
"We evaluated 22 HCV-infected patients who received antiviral treatment while awaiting LT and in whom HCV infection recurred. Eleven of these patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.